· 2 min read
Manganese Outperforms Magnesium in Mouse Embryo DNA-Building Enzyme
By Kristense at Havdis AI Science Team, approved by Andreas Lyhammer
· 2 min read
By Kristense at Havdis AI Science Team, approved by Andreas Lyhammer

Based on the PubMed abstract — the full text of this paper was not freely available.
Birnie and Fox, writing in The Biochemical Journal in 1967, studied how an enzyme from mouse embryo tissue assembles polydeoxyribonucleotide, a DNA-like chain of nucleotide building blocks. This is basic enzymology, not a skin or medical study: the goal was to understand the chemistry of a DNA-building enzyme, not any therapeutic effect.
Working with cell-free extracts prepared from mouse embryos, the researchers tracked how the enzyme incorporated a radioactively labeled building block, tritium-tagged thymidine triphosphate, into new nucleotide chains. They found the enzyme, DNA nucleotidyltransferase (which adds nucleotide units onto a growing DNA strand), required all four matching DNA building blocks, a template strand to copy, and a metal ion to function, matching the behavior of similar enzymes already known from other mammalian tissues.
One feature stood out: unlike many other mammalian versions of this enzyme, the mouse embryo enzyme worked far faster and more completely with manganese ions than with magnesium ions. Both metals produced peak activity at pH 6.4, but at that pH manganese boosted the reaction six to eight times more than magnesium did.
The paper reports only enzyme behavior in a test-tube extract. It says nothing about living cells, whole animals, or any medical or cosmetic use.
Our reflection
This 1967 study sits at the roots of nucleic-acid biochemistry, long before polydeoxyribonucleotides were considered for skin or wound applications. It shows the kind of patient, foundational enzyme research, mapping exactly how DNA chains get built and under what conditions, that today's PDRN science ultimately grew out of.
Source
Birnie GD, Fox SM (1967). The Biochemical journal.
Read the paper on PubMedDOI: 10.1042/bj1040239Free full text (PMC)
This article is written by Havdis's AI Science Team to explain published research. It is not medical advice, and nothing here is a claim about any Havdis product.
Related
A 1991 Haemostasis study on how defibrotide, a polydeoxyribonucleotide-derived drug, suppresses monocyte superoxide generation in vitro.
Read more →1989 rat study: defibrotide, a polydeoxyribonucleotide, limited ischemia-reperfusion damage to liver and heart energy metabolism.
Read more →1988 Journal of Bacteriology study on how a yeast polydeoxyribonucleotide ligase repairs bleomycin-induced DNA strand breaks.
Read more →